The funders of the mRNA Technology Transfer Programme
The Programme continues to receive exceptional support both from high-income countries and from LMICs. This is seed money and the aim is for the project to be self-sustaining after 2026. Funds are used to cover the overall coordination of the project, the establishment of the mRNA Consortium activities in South Africa, the development of innovation and products and to directly support the Programme Partners for technology transfer. A large portion of the funds has been secured.
Secured funds are from: Belgium, Canada, European Commission, France, Germany, Norway, South African Government and South African Medical Research Council (SAMRC).
For More Information On Our Funders (click on the logos below)
